Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)
Clinical trial NCT05787639 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05787639
- Sponsor
- University of California, San Diego
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-23
- Primary completion
- 2026-10-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.